[dr Deana B. Andric]

Faculty of Chemistry, Studentski trg 12-16, Beograd
Department of Organic Chemistry

Phone:   011-3336759

Phone (local):   759

Office:   476

Laboratory:   463

E-mail:   deanad@chem.bg.ac.rs

Personal data

Born on January 20, 1963 in Belgrade, Serbia. Married. Speaks Serbian and English language.

Education and qualifications

1981-1987: Undergraduate studies - Chemistry / Prirodno-matematički fakultet (Belgrade, Serbia)

1987-1991: Master of science studies - Chemistry / University of Belgrade - Faculty of Chemistry (Belgrade, Serbia)

1992-1996: Doctoral academic (PhD) studies - Chemistry / University of Belgrade - Faculty of Chemistry (Belgrade, Serbia)

History of employment

1989-1991: IHTM (Belgrade, Serbia)

1991-1999: Teaching assistant / Veterinarski fakultet (Belgrade, Serbia)

1999-2010: Assistant professor / University of Belgrade - Faculty of Chemistry (Belgrade, Serbia)

2010-2024: Associate professor / University of Belgrade - Faculty of Chemistry (Belgrade, Serbia)

2024: Full professor / University of Belgrade - Faculty of Chemistry (Belgrade, Serbia)

Scientific interest

Medicinal chemistry - synthesis and investigation of dopaminergic and serotonergic activity of synthesized ligands, computational chemistry modeling of ligand-acceptor interactions

Other activities

Member of Serbian Chemical Society from January 1, 1989 - Section for medicinal chemistry; Section for organic chemistry.

Vice Dean for Finance from May 19, 2007 till May 19, 2010.

Chairman of the Committee for Disciplinary Responsibility of Students from July 12, 2021.

Deputy chairman of the Ethical Committee from November 9, 2023.

Educational activities

Participation in research projects

Finished projects:

  • 2011: Structure-activity relationship of newly synthesized biological active compounds – 172032
    project type:   National Fundamental Research Projects
    project is funded by: Ministry of Science and Technological Development (Belgrade, Serbia)

Author identification numbers

Representative references

Knjige i revijalni radovi / Books and reviews:

  1. Prof. dr Danica Katanić, doc. dr Deana Dragović, asis. mr Iris Đorđević: Praktikum iz hemije sa računskim zadacima, /Fakultet veterinarske medicine, Univerzitet u Beogradu, Beograd 1999./
  2. Dr Deana Andrić, dr Goran Roglić: Radni listovi iz organske hemije/Hemijski fakultet Univerzitet u Beogradu, Beograd 2010./

Izabrani radovi / Selected papers:

  1. Roglić, Goran; Andrić, Deana; Kostić-Rajačić, Slađana; Dukić, Slađana; Šoškić, Vukić: Introduction of a methyl group in α- or β- position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties. Arch. Pharm. (2001), 334, 373-378.
  2. Roglić Goran; Dukić-Stefanović, Slađana; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines. Pharmazie (2001), 56, 803-807.
  3. Šukalović, Vladimir; Roglić, Goran; Husinec, Suren; Kostić-Rajačić, Slađana; Andrić, Deana; Šoškić, Vukić: D2 dopaminergic 5HT1A serotonergic activity of 2-(1-naphtyl)ethyl- and 2-(2-naphtyl)ethyl amines. Arch. Pharm. (2003), 336, 514-522.
  4. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Vasilev, Vesna; Dragović, Deana; Roglić, Goran; Ignjatović, Đurđica; Šoškić, Vukić; Kostić-Rajačić, Slađana: Pharmacological evaluation of 5-(2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl)-1,3-dihydro-benzimidazole-2-thione as a potential atypical antipsychotic agent. Pharmazie (2003), 58, 677-678.
  5. Šukalović, Vladimir; Andrić, Deana; Kostić Rajačić, Slađana; Roglić Goran; Šoškić, Vukić: Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Arch. Pharm. (2004), 337, 376-382.
  6. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Kostić-Rajačić, Slađana; Roglić, Goran; Šoškić, Vukić: Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-(2-[5-(1/H/-benzimidazole-2-thione)]ethyl)-4-arylpiperazines. Arch. Pharm. (2004), 337, 502-512.
  7. Veličković, Jelena; Andrić, Deana; Roglić, Goran; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Planar chromatography of some 1-arylpiperazines behaving as dopaminergic ligands. JPC-J. Planar. Chromat. (2004), 17, 255-260.
  8. Tomić, Mirko; Kundaković, Marija; Butorović, Biljana; Janać, Branka; Andrić, Deana; Roglić, Goran; Ignjatović, Đurđica; Kostić-Rajačić, Slađana: Pharmacological evaluation of selected arylpiperazines with atypicalantipsychotic potential. Bioorg. Med. Chem. Lett. (2004), 14, 4263-4266.
  9. Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Schrattenholz, Andreas; Šoškić, Vukić: Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-3-(4-arylpiperazin-1-yl)propyl-1H-benzimidazole, 5-2-(4-arylpiperazin-1-yl)ethoxy-1H-benzimidazole and their analogues. Eur. J. Med. Chem. (2005), 40, 481-493.
  10. Šukalović, Vladimir; Zlatović Mario; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana; Šoškić, Vukić: Interaction of arylpiperazines with the D2 dopamine receptor binding site. Arzneimittel-Forsch./Drug Res. (2005), 55, 145-152.
  11. Zlatović Mario; Šukalović, Vladimir; Kostić-Rajačić, Slađana; Andrić, Deana; Roglić, Goran: Influence of N-1 substituent properties on binding affinities of arylpiperazines to the binding site of 5-HT1A receptor. J.Serb.Chem.Soc. (2006), 71(11), 1125-1135.
  12. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Vasković, Đurđica; Šoškić, Vukić; Tomić, Mirko; Kostić-Rajačić, Slađana: Synthesis and pharmacological evaluation of several N-(2-nitrophenyl)piperazine derivatives. J.Serb.Chem.Soc. (2007),72(5), 429-435.
  13. Andrić, Deana; Tovilović, Gordana; Roglić, Goran; Šoškić, Vukić, Tomić, Mirko; Kostić-Rajačić, Slađana: 6-[2-(4-Arylpiperazin-1-yl)ethyl]-4-halo-1,3-dihydro-2H-benzimidazole-2-thiones: synthesis and pharmacological evaluation. J.Serb.Chem.Soc. (2007), 72(8-9), 747-755.
  14. Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić; Roglić, Goran: 1-Cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D2) and serotonin (5-HT1A) receptors. Arch. Pharm. Chem. Life Sci. (2007), 340, 456-465.
  15. Tomić, Mirko; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Two new phenylpiperazines with atypical antipsychotic potential. Bioorg. Med. Chem. Lett. (2007), 17, 5749-5753.
  16. Andrić, Deana; Roglić, Goran; Šukalović, Vladimir; Šoškić, Vukić; Kostić-Rajačić, Slađana: Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2- and 5-HT1A receptors. Eur. J. Med. Chem. (2008), 43, 1696-1705.
  17. Šukalović, Vladimir; Zlatović, Mario; Roglić, Goran; Kostić-Rajačić, Slađana; Andrić, Deana: Application of hybrid density functional theory in calculation edge-to-face interactions of receptor-ligand system. Acta. Chim. Slov. (2009), 56, 270-277.
  18. Trfković, Jelena; Andrić, Filip; Ristivojević, P.; Andrić, Deana; Tešić, Živoslav; Milojković-Opsenica, Dušanka: Structure-retention relationship studz of arylpiperazines by linear multivariate modeling. J. Sep. Sci. (2010), 33, 2619-2628.
  19. Tomić, Mirko; Vasković, Đurđica; Tovilović, Gordana; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Pharmacological evaluation of halogenated and non-halogenated arylpiperazin-1-yl-ethyl-benzimidazoles as D2 and 5-HT2A receptor ligands. Arch. Pharm. Chem. Life Sci. (2011), 344(5), 287-291.
  20. Senćanski, Milan; Šukalović, Vladimir; Došen-Mićović, Ljiljana; Šoškić, Vukić; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Modeling interactions of alpha (1a) adenergic receptor and different arylpiperazine ligands. Dig. J. Nanomater. Bios. (2012), 7(4), 1767-1777.
  21. Šukalović, Vladimir; Ignjatović, Đurđica; Tovilović, Gordana; Andrić, Deana; Shakib, K.; Kostić-Rajačić, Slađana; Vukić, Šoškić: Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxyltryptamine 5HT1A receptors. Bioorg. Med. Chem. Lett. (2012), 22(12), 3967-3972.
  22. Ignjatović, Đurđica; Vojnović Milutinović, D.; Nikolić-Kokić, A.; Slavić, M.; Andrić, Deana; Tomić, Mirko; Kostić-Rajačić, Slađana: The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside. Eur. J. Pharmacol. (2012), 683, 93-100.
  23. Šulalović, Vladimir; Šoškić, Vukić; Andrić, Deana, Roglić, Goran; Kostić-Rajačić, Slađana: Modeling key interactions between dopamine D2 receptor second extracellular loop and arylpiperazine ligands. J. Serb. Chem. Soc. (2012), 77(3), 259-277.
  24. Novaković, Irena; Penjišević, Jelena; Šukalović, Vladimir; Andrić, Deana; Roglić, Goran; Kostić-Rajačić, Slađana: Investigation of antibacterial activity of cinnamyl derivates of arylpiperazine. Arch. Biol. Sci. (2012), 64(1), 15-20.
  25. Šukalović, Vladimir; Bogdan, A.E.; Tovilović, Gordana; Ignjatović, Đurđica; Andrić, Deana; Kostić-Rajačić, Slađana; Šoškić, Vukić: N-{[2-(4-Phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides with dopamine D2 and 5-hydroxytryptamine 5HT1A activity: synthesis, testing and molecular modeling. Arch. Pharm. Chem. Life Sci. (2013), 346, 708-717.
  26. Šukalović, Vladimir; Šiškić, Vukić; Senćanski, Milan; Andrić, Deana; Kostić-Rajačić, Slađana: Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model. J. Mol. Model. (2013), 19(4), 1751-1762.
  27. Vasić, Vesna; Penjišević, Jelena; Novaković, Irena; Šukalović, Vladimir; Andrić, Deana; Kostić-Rajačić, Slađana: Synthesis and biological evaluation of 5-substituted derivatives of benzimidazole. J. Serb. Chem. Soc. (2014), 79(3), 277-282.
  28. Šukalović, Vladimir; Šoškić, Vukić; Ignjatović, Đurđica; Andrić, Deana; Penjišević, Jelena; Kostić-Rajačić, Slađana: Investigation of key interactions between the second extracellular loop of the dopamine D2 receptor and several hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}-nicotinamides. J. Serb. Chem. Soc. (2014), 79(12), 1461-1467.